GLP-1 Agonists Tied to Lower Risk of Death in Dialysis Patients

(MedPage Today) — Use of GLP-1 receptor agonists was associated with a lower risk of mortality for dialysis patients with type 2 diabetes, according to a retrospective cohort study of Medicare enrollees.
Among over 151,000 patients, use of GLP…

Source link : https://www.medpagetoday.com/meetingcoverage/obesityweek/118321

Author :

Publish date : 2025-11-05 18:12:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

GLP-1 Agonists Tied to Lower Risk of Death in Dialysis Patients

Here’s how to spot the Leonid meteor shower this month

Caution Urged for Virtual Care Partnerships in Canada

Related Posts

Heart-Related Deaths Rise in Young Adults With Diabetes

Empagliflozin Benefits HF Patients With High Serum Magnesium

Woman hospitalised over dessert containing nuts at Bradford business

Inside the Clinics Weathering America’s ICE Raids

Income Struggles Linked to Altered Brain Growth in Infants

What’s Driving CV Deaths in RA: Inflammation or Antibodies?

Heart-Related Deaths Rise in Young Adults With Diabetes

Empagliflozin Benefits HF Patients With High Serum Magnesium

Woman hospitalised over dessert containing nuts at Bradford business

Inside the Clinics Weathering America’s ICE Raids

Income Struggles Linked to Altered Brain Growth in Infants

What’s Driving CV Deaths in RA: Inflammation or Antibodies?

Pulse Oximeter Failings for Darker-Skinned People Might Not Have a Simple Solution

U.S. Health Spending Topped $5 Trillion in 2024, CMS Says

Categories

Archives